Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 402 entries
Sorted by: Best Match Show Resources per page
Novel near-infrared emission from crystal defects in MoS.

Nature communications

Fabbri F, Rotunno E, Cinquanta E, Campi D, Bonnini E, Kaplan D, Lazzarini L, Bernasconi M, Ferrari C, Longo M, Nicotra G, Molle A, Swaminathan V, Salviati G.
PMID: 27698425
Nat Commun. 2016 Oct 04;7:13044. doi: 10.1038/ncomms13044.

The structural defects in two-dimensional transition metal dichalcogenides, including point defects, dislocations and grain boundaries, are scarcely considered regarding their potential to manipulate the electrical and optical properties of this class of materials, notwithstanding the significant advances already made....

Cite
Fabbri F, Rotunno E, Cinquanta E, et al. Novel near-infrared emission from crystal defects in MoS. Nat Commun. 2016;7:13044doi: 10.1038/ncomms13044.
Fabbri, F., Rotunno, E., Cinquanta, E., Campi, D., Bonnini, E., Kaplan, D., Lazzarini, L., Bernasconi, M., Ferrari, C., Longo, M., Nicotra, G., Molle, A., Swaminathan, V., & Salviati, G. (2016). Novel near-infrared emission from crystal defects in MoS. Nature communications, 713044. https://doi.org/10.1038/ncomms13044
Fabbri, F, et al. "Novel near-infrared emission from crystal defects in MoS." Nature communications vol. 7 (2016): 13044. doi: https://doi.org/10.1038/ncomms13044
Fabbri F, Rotunno E, Cinquanta E, Campi D, Bonnini E, Kaplan D, Lazzarini L, Bernasconi M, Ferrari C, Longo M, Nicotra G, Molle A, Swaminathan V, Salviati G. Novel near-infrared emission from crystal defects in MoS. Nat Commun. 2016 Oct 04;7:13044. doi: 10.1038/ncomms13044. PMID: 27698425; PMCID: PMC5059461.
Copy Download .nbib Format: NLM
Impact of preoperative testing on ophthalmologic and systemic outcomes in cataract surgery.

European journal of ophthalmology

Cavallini GM, Saccarola P, Gasparin A, Campi L.
PMID: 28221485
Eur J Ophthalmol. 2004 Sep - Oct 2004;14(5):369-374. doi: 10.5301/EJO.2008.2689.

PURPOSE: To evaluate the incidence of ophthalmologic and systemic complications in patients who undergo cataract surgery without preoperative tests compared to subjects undergoing cataract surgery preceded by preoperative tests.METHODS: The randomized controlled study included 1276 consecutive patients admitted to...

Cite
Cavallini GM, Saccarola P, Gasparin A, et al. Impact of preoperative testing on ophthalmologic and systemic outcomes in cataract surgery. Eur J Ophthalmol. 2004;14(5):369-374doi: 10.5301/EJO.2008.2689.
Cavallini, G. M., Saccarola, P., Gasparin, A., & Campi, L. (2004). Impact of preoperative testing on ophthalmologic and systemic outcomes in cataract surgery. European journal of ophthalmology, 14(5), 369-374. https://doi.org/10.5301/EJO.2008.2689
Cavallini, G M, et al. "Impact of preoperative testing on ophthalmologic and systemic outcomes in cataract surgery." European journal of ophthalmology vol. 14,5 (2004): 369-374. doi: https://doi.org/10.5301/EJO.2008.2689
Cavallini GM, Saccarola P, Gasparin A, Campi L. Impact of preoperative testing on ophthalmologic and systemic outcomes in cataract surgery. Eur J Ophthalmol. 2004 Sep - Oct 2004;14(5):369-374. doi: 10.5301/EJO.2008.2689. PMID: 28221485.
Copy Download .nbib Format: NLM
Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?.

OncoTargets and therapy

Kus T, Aktas G, Sevinc A, Kalender ME, Camci C.
PMID: 26150726
Onco Targets Ther. 2015 Jun 05;8:1341-3. doi: 10.2147/OTT.S84480. eCollection 2015.

Erlotinib, an epidermal growth factor receptor and tyrosine kinase inhibitor, is a targeted drug that was approved for the treatment of non-small-cell lung cancers and pancreatic cancers. Targeted tyrosine kinase inhibitors are known to have cardiotoxic effects. However, erlotinib...

Cite
Kus T, Aktas G, Sevinc A, et al. Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?. Onco Targets Ther. 2015;8:1341-3doi: 10.2147/OTT.S84480.
Kus, T., Aktas, G., Sevinc, A., Kalender, M. E., & Camci, C. (2015). Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?. OncoTargets and therapy, 81341-3. https://doi.org/10.2147/OTT.S84480
Kus, Tulay, et al. "Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?." OncoTargets and therapy vol. 8 (2015): 1341-3. doi: https://doi.org/10.2147/OTT.S84480
Kus T, Aktas G, Sevinc A, Kalender ME, Camci C. Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?. Onco Targets Ther. 2015 Jun 05;8:1341-3. doi: 10.2147/OTT.S84480. eCollection 2015. PMID: 26150726; PMCID: PMC4485179.
Copy Download .nbib Format: NLM
Epidemiology, patient profile, and health care resource use for hepatitis C in Italy.

ClinicoEconomics and outcomes research : CEOR

Sangiorgi D, Perrone V, Buda S, Boglione L, Cariti G, Lefevre C, Nappi C, Degli Esposti L.
PMID: 29066922
Clinicoecon Outcomes Res. 2017 Oct 10;9:609-616. doi: 10.2147/CEOR.S136456. eCollection 2017.

OBJECTIVE: The objectives of this study were to estimate the prevalence of Hepatitis C among six Italian Local Health Units (LHUs), to describe patient and antiviral drug characteristics, and to estimate the health care consumption rates and related costs...

Cite
Sangiorgi D, Perrone V, Buda S, et al. Epidemiology, patient profile, and health care resource use for hepatitis C in Italy. Clinicoecon Outcomes Res. 2017;9:609-616doi: 10.2147/CEOR.S136456.
Sangiorgi, D., Perrone, V., Buda, S., Boglione, L., Cariti, G., Lefevre, C., Nappi, C., & Degli Esposti, L. (2017). Epidemiology, patient profile, and health care resource use for hepatitis C in Italy. ClinicoEconomics and outcomes research : CEOR, 9609-616. https://doi.org/10.2147/CEOR.S136456
Sangiorgi, Diego, et al. "Epidemiology, patient profile, and health care resource use for hepatitis C in Italy." ClinicoEconomics and outcomes research : CEOR vol. 9 (2017): 609-616. doi: https://doi.org/10.2147/CEOR.S136456
Sangiorgi D, Perrone V, Buda S, Boglione L, Cariti G, Lefevre C, Nappi C, Degli Esposti L. Epidemiology, patient profile, and health care resource use for hepatitis C in Italy. Clinicoecon Outcomes Res. 2017 Oct 10;9:609-616. doi: 10.2147/CEOR.S136456. eCollection 2017. PMID: 29066922; PMCID: PMC5644550.
Copy Download .nbib Format: NLM
0.85  PW laser operation at 3.3  Hz and high-contrast ultrahigh-intensity λ = 400  nm second-harmonic beamline.

Optics letters

Wang Y, Wang S, Rockwood A, Luther BM, Hollinger R, Curtis A, Calvi C, Menoni CS, Rocca JJ.
PMID: 28957138
Opt Lett. 2017 Oct 01;42(19):3828-3831. doi: 10.1364/OL.42.003828.

We demonstrate the generation of 0.85 PW, 30 fs laser pulses at a repetition rate of 3.3 Hz with a record average power of 85 W from a Ti:sapphire laser. The system is pumped by high-energy Nd:glass slab amplifiers...

Cite
Wang Y, Wang S, Rockwood A, et al. 0.85  PW laser operation at 3.3  Hz and high-contrast ultrahigh-intensity λ = 400  nm second-harmonic beamline. Opt Lett. 2017;42(19):3828-3831doi: 10.1364/OL.42.003828.
Wang, Y., Wang, S., Rockwood, A., Luther, B. M., Hollinger, R., Curtis, A., Calvi, C., Menoni, C. S., & Rocca, J. J. (2017). 0.85  PW laser operation at 3.3  Hz and high-contrast ultrahigh-intensity λ = 400  nm second-harmonic beamline. Optics letters, 42(19), 3828-3831. https://doi.org/10.1364/OL.42.003828
Wang, Yong, et al. "0.85  PW laser operation at 3.3  Hz and high-contrast ultrahigh-intensity λ = 400  nm second-harmonic beamline." Optics letters vol. 42,19 (2017): 3828-3831. doi: https://doi.org/10.1364/OL.42.003828
Wang Y, Wang S, Rockwood A, Luther BM, Hollinger R, Curtis A, Calvi C, Menoni CS, Rocca JJ. 0.85  PW laser operation at 3.3  Hz and high-contrast ultrahigh-intensity λ = 400  nm second-harmonic beamline. Opt Lett. 2017 Oct 01;42(19):3828-3831. doi: 10.1364/OL.42.003828. PMID: 28957138.
Copy Download .nbib Format: NLM
Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer.

Molecular and clinical oncology

Kus T, Aktas G, Sevinc A, Oktay C, Kalender ME, Camci C.
PMID: 26893877
Mol Clin Oncol. 2016 Feb;4(2):290-292. doi: 10.3892/mco.2015.677. Epub 2015 Nov 13.

Hepatocellular carcinoma (HCC) and renal cell cancer (RCC) are malignancies, which are chemotherapy resistant and fatal at the advanced stages. Previously developed tyrosine kinase inhibitors are used in the treatment of advanced stage disease. In the present case study,...

Cite
Kus T, Aktas G, Sevinc A, et al. Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer. Mol Clin Oncol. 2015;4(2):290-292doi: 10.3892/mco.2015.677.
Kus, T., Aktas, G., Sevinc, A., Oktay, C., Kalender, M. E., & Camci, C. (2016). Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer. Molecular and clinical oncology, 4(2), 290-292. https://doi.org/10.3892/mco.2015.677
Kus, Tulay, et al. "Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer." Molecular and clinical oncology vol. 4,2 (2016): 290-292. doi: https://doi.org/10.3892/mco.2015.677
Kus T, Aktas G, Sevinc A, Oktay C, Kalender ME, Camci C. Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer. Mol Clin Oncol. 2016 Feb;4(2):290-292. doi: 10.3892/mco.2015.677. Epub 2015 Nov 13. PMID: 26893877; PMCID: PMC4734193.
Copy Download .nbib Format: NLM
Probing transport mechanisms of BaFe₂As₂ superconducting films and grain boundary junctions by noise spectroscopy.

Scientific reports

Barone C, Romeo F, Pagano S, Adamo M, Nappi C, Sarnelli E, Kurth F, Iida K.
PMID: 25145385
Sci Rep. 2014 Aug 22;4:6163. doi: 10.1038/srep06163.

An important step forward for the understanding of high-temperature superconductivity has been the discovery of iron-based superconductors. Among these compounds, iron pnictides could be used for high-field magnet applications, resulting more advantageous over conventional superconductors, due to a high...

Cite
Barone C, Romeo F, Pagano S, et al. Probing transport mechanisms of BaFe₂As₂ superconducting films and grain boundary junctions by noise spectroscopy. Sci Rep. 2014;4:6163doi: 10.1038/srep06163.
Barone, C., Romeo, F., Pagano, S., Adamo, M., Nappi, C., Sarnelli, E., Kurth, F., & Iida, K. (2014). Probing transport mechanisms of BaFe₂As₂ superconducting films and grain boundary junctions by noise spectroscopy. Scientific reports, 46163. https://doi.org/10.1038/srep06163
Barone, C, et al. "Probing transport mechanisms of BaFe₂As₂ superconducting films and grain boundary junctions by noise spectroscopy." Scientific reports vol. 4 (2014): 6163. doi: https://doi.org/10.1038/srep06163
Barone C, Romeo F, Pagano S, Adamo M, Nappi C, Sarnelli E, Kurth F, Iida K. Probing transport mechanisms of BaFe₂As₂ superconducting films and grain boundary junctions by noise spectroscopy. Sci Rep. 2014 Aug 22;4:6163. doi: 10.1038/srep06163. PMID: 25145385; PMCID: PMC4141261.
Copy Download .nbib Format: NLM
Diabetologic in-service education for health professionals from non-diabetological departments.

Acta diabetologica

Piaggesi A, Schipani E, Ceraudo AM, Baccetti F, Campi F, Navalesi R.
PMID: 9033968
Acta Diabetol. 1996 Dec;33(4):277-83. doi: 10.1007/BF00571565.

In order to test whether or not an in-service requalification course on diabetes care for health professionals (HP) of nondiabetological departments can enhance their level of knowledge about diabetes and the quality of care for diabetic inpatients admitted for...

Cite
Piaggesi A, Schipani E, Ceraudo AM, et al. Diabetologic in-service education for health professionals from non-diabetological departments. Acta Diabetol. 1996;33(4):277-83doi: 10.1007/BF00571565.
Piaggesi, A., Schipani, E., Ceraudo, A. M., Baccetti, F., Campi, F., & Navalesi, R. (1996). Diabetologic in-service education for health professionals from non-diabetological departments. Acta diabetologica, 33(4), 277-83. https://doi.org/10.1007/BF00571565
Piaggesi, A, et al. "Diabetologic in-service education for health professionals from non-diabetological departments." Acta diabetologica vol. 33,4 (1996): 277-83. doi: https://doi.org/10.1007/BF00571565
Piaggesi A, Schipani E, Ceraudo AM, Baccetti F, Campi F, Navalesi R. Diabetologic in-service education for health professionals from non-diabetological departments. Acta Diabetol. 1996 Dec;33(4):277-83. doi: 10.1007/BF00571565. PMID: 9033968.
Copy Download .nbib Format: NLM
Is cardiology consultation required before cardiac catheterization?.

European journal of internal medicine

Jotkowitz AB, Cafri C, Dakwar JS, Fischer NE, Ilia R, Schlaeffer F.
PMID: 15288675
Eur J Intern Med. 2004 Jul;15(4):220-224. doi: 10.1016/j.ejim.2004.04.002.

Background: In many hospitals, internists have begun to directly refer patients for cardiac catheterization without a prior cardiology consultation. The purpose of this study is to compare the results of a policy of mandatory consultation prior to catheterization with...

Cite
Jotkowitz AB, Cafri C, Dakwar JS, et al. Is cardiology consultation required before cardiac catheterization?. Eur J Intern Med. 2004;15(4):220-224doi: 10.1016/j.ejim.2004.04.002.
Jotkowitz, A. B., Cafri, C., Dakwar, J. S., Fischer, N. E., Ilia, R., & Schlaeffer, F. (2004). Is cardiology consultation required before cardiac catheterization?. European journal of internal medicine, 15(4), 220-224. https://doi.org/10.1016/j.ejim.2004.04.002
Jotkowitz, Alan B., et al. "Is cardiology consultation required before cardiac catheterization?." European journal of internal medicine vol. 15,4 (2004): 220-224. doi: https://doi.org/10.1016/j.ejim.2004.04.002
Jotkowitz AB, Cafri C, Dakwar JS, Fischer NE, Ilia R, Schlaeffer F. Is cardiology consultation required before cardiac catheterization?. Eur J Intern Med. 2004 Jul;15(4):220-224. doi: 10.1016/j.ejim.2004.04.002. PMID: 15288675.
Copy Download .nbib Format: NLM
Malignant histiocytosis of the skin: a case report and review of the literature.

Journal of dermatological case reports

Demers NM, Bowers J, Appin C, Morgan MB.
PMID: 21886719
J Dermatol Case Rep. 2009 Apr 05;3(1):4-7. doi: 10.3315/jdcr.2009.1024.

BACKGROUND: Malignant histiocytosis is a rare neoplasm composed of abnormal histiocytes typically affecting the liver, spleen, lymph nodes, and bone marrow. This entity has been rarely documented involving the skin and has never been reported confined to the skin.MAIN...

Cite
Demers NM, Bowers J, Appin C, et al. Malignant histiocytosis of the skin: a case report and review of the literature. J Dermatol Case Rep. 2009;3(1):4-7doi: 10.3315/jdcr.2009.1024.
Demers, N. M., Bowers, J., Appin, C., & Morgan, M. B. (2009). Malignant histiocytosis of the skin: a case report and review of the literature. Journal of dermatological case reports, 3(1), 4-7. https://doi.org/10.3315/jdcr.2009.1024
Demers, Nicole M, et al. "Malignant histiocytosis of the skin: a case report and review of the literature." Journal of dermatological case reports vol. 3,1 (2009): 4-7. doi: https://doi.org/10.3315/jdcr.2009.1024
Demers NM, Bowers J, Appin C, Morgan MB. Malignant histiocytosis of the skin: a case report and review of the literature. J Dermatol Case Rep. 2009 Apr 05;3(1):4-7. doi: 10.3315/jdcr.2009.1024. PMID: 21886719; PMCID: PMC3157786.
Copy Download .nbib Format: NLM
Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients.

Clinical lung cancer

Camps C, Sarries C, Roig B, Sanchez JJ, Queralt C, Sancho E, Martinez N, Tarón M, Rosell R.
PMID: 14624713
Clin Lung Cancer. 2003 Jan;4(4):237-41. doi: 10.3816/clc.2003.n.004.

Only about one third of non-small-cell lung cancer (NSCLC) patients respond to cisplatin-based chemotherapy. Cisplatin DNA adducts are commonly repaired through the nucleotide excision repair pathway. The study of rare inherited disorders such as xeroderma pigmentosum and Cockayne syndrome...

Cite
Camps C, Sarries C, Roig B, et al. Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients. Clin Lung Cancer. 2003;4(4):237-41doi: 10.3816/clc.2003.n.004.
Camps, C., Sarries, C., Roig, B., Sanchez, J. J., Queralt, C., Sancho, E., Martinez, N., Tarón, M., & Rosell, R. (2003). Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients. Clinical lung cancer, 4(4), 237-41. https://doi.org/10.3816/clc.2003.n.004
Camps, Carlos, et al. "Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients." Clinical lung cancer vol. 4,4 (2003): 237-41. doi: https://doi.org/10.3816/clc.2003.n.004
Camps C, Sarries C, Roig B, Sanchez JJ, Queralt C, Sancho E, Martinez N, Tarón M, Rosell R. Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients. Clin Lung Cancer. 2003 Jan;4(4):237-41. doi: 10.3816/clc.2003.n.004. PMID: 14624713.
Copy Download .nbib Format: NLM
Conformational features and recognition properties of a conformationally blocked calix[7]arene derivative.

Chemistry (Weinheim an der Bergstrasse, Germany)

Gaeta C, Talotta C, Farina F, Campi G, Camalli M, Neri P.
PMID: 22179991
Chemistry. 2012 Jan 23;18(4):1219-30. doi: 10.1002/chem.201102179. Epub 2011 Dec 16.

The shaping of a calix[7]arene macrocycle into cone-like structure 3, through exhaustive alkylation of doubly bridged calix[7]arene derivative 2 with bulky groups, has been investigated. Conformational details about the structure adopted by calix[7]arene derivative 3 in solution have been...

Cite
Gaeta C, Talotta C, Farina F, et al. Conformational features and recognition properties of a conformationally blocked calix[7]arene derivative. Chemistry. 2011;18(4):1219-30doi: 10.1002/chem.201102179.
Gaeta, C., Talotta, C., Farina, F., Campi, G., Camalli, M., & Neri, P. (2012). Conformational features and recognition properties of a conformationally blocked calix[7]arene derivative. Chemistry (Weinheim an der Bergstrasse, Germany), 18(4), 1219-30. https://doi.org/10.1002/chem.201102179
Gaeta, Carmine, et al. "Conformational features and recognition properties of a conformationally blocked calix[7]arene derivative." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 18,4 (2012): 1219-30. doi: https://doi.org/10.1002/chem.201102179
Gaeta C, Talotta C, Farina F, Campi G, Camalli M, Neri P. Conformational features and recognition properties of a conformationally blocked calix[7]arene derivative. Chemistry. 2012 Jan 23;18(4):1219-30. doi: 10.1002/chem.201102179. Epub 2011 Dec 16. PMID: 22179991.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 402 entries